Subsequent administration of anti‐PD‐1 inhibitors to the orthotopic buccal syngeneic model decreased the tumor volume and weight in the treatment group compared to those in the control group (Fig. 3F–J). This evidence concerns the gene PDCD1 and neoplasm.